15,110 Shares in Select Medical Holdings Co. (NYSE:SEM) Acquired by Phocas Financial Corp.

Phocas Financial Corp. bought a new stake in Select Medical Holdings Co. (NYSE:SEM - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 15,110 shares of the health services provider's stock, valued at approximately $285,000.

Other large investors have also recently bought and sold shares of the company. Quarry LP bought a new position in shares of Select Medical during the third quarter worth approximately $30,000. Wilmington Savings Fund Society FSB bought a new position in Select Medical during the third quarter worth $81,000. Virtu Financial LLC bought a new position in Select Medical during the third quarter worth $210,000. Quantbot Technologies LP bought a new position in Select Medical during the third quarter worth $232,000. Finally, Tidal Investments LLC bought a new position in Select Medical during the third quarter worth $286,000. 89.48% of the stock is owned by institutional investors.

Insider Buying and Selling at Select Medical

In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business's stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now directly owns 30,356 shares in the company, valued at $605,602.20. The trade was a 14.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 19.14% of the company's stock.

Select Medical Stock Down 1.5 %

Shares of NYSE SEM traded down $0.27 during mid-day trading on Friday, reaching $18.19. 2,143,734 shares of the company's stock traded hands, compared to its average volume of 932,006. The stock has a market cap of $2.35 billion, a P/E ratio of 11.02, a PEG ratio of 0.64 and a beta of 1.45. The business has a 50-day simple moving average of $19.06 and a 200 day simple moving average of $27.44. Select Medical Holdings Co. has a 1-year low of $16.20 and a 1-year high of $40.98. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The firm had revenue of $1.31 billion for the quarter, compared to analysts' expectations of $1.50 billion. On average, analysts expect that Select Medical Holdings Co. will post 1.17 EPS for the current fiscal year.

Select Medical Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd will be paid a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date is Monday, March 3rd. Select Medical's payout ratio is 15.15%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Royal Bank of Canada decreased their price target on shares of Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a research note on Monday, February 24th. StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target for the company in a research note on Monday, February 24th. Finally, UBS Group decreased their price target on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a research note on Friday, January 3rd. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $27.25.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.